synthetic pentadecapeptide
BPC-157 updates
Answer
7 changes for BPC-157 in the last 12 months. Latest: 2026-09-03.
| Date | Type | What changed | Source |
|---|---|---|---|
| 2026-09-03 | Trial | New trial registered: Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery | Trial register ClinicalTrials.gov |
| 2026-08-03 | Trial | New trial registered: A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery | Trial register ClinicalTrials.gov |
| 2026-04-16 | Action | Ohio Board of Pharmacy: board | Regulator Ohio Board of Pharmacy |
| 2026-04-16 | Federal Register | Federal Register notice: Pharmacy Compounding Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Bulk Drug Substances Nominated | Regulator Federal Register |
| 2026-02-22 | Trial | New trial registered: BPC 157 for Acute Hamstring Muscle Strain Repair | Trial register ClinicalTrials.gov |
| 2025-10-15 | Recall | FDA recall, Class II: GenoGenix LLC. Lack of Assurance of Sterility | Regulator FDA enforcement reports |
| 2025-10-15 | Recall | FDA recall, Class II: GenoGenix LLC. Lack of Assurance of Sterility | Regulator FDA enforcement reports |
| 2023-12-04 | Action | California Board of Pharmacy: board | Regulator California Board of Pharmacy |
| 2023-06-12 | Warning letter | FDA warning letter to Warrior Labz SARMS: Unapproved New Drugs/Misbranded | Regulator FDA warning letters |
| 2022-04-27 | Recall | FDA recall, Class II: North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding. Lack of Assurance of Sterility: deviations from Current Good Manu | Regulator FDA enforcement reports |
| 2021-11-10 | Warning letter | FDA warning letter to Advanced Nutriceuticals, LLC dba The Guyer Institute of Molecular Medicine: Compounding Pharmacy/Adulterated Drug Products | Regulator FDA warning letters |
| 2020-12-23 | Recall | FDA recall, Class II: Advanced Nutriceuticals, LLC. Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products in | Regulator FDA enforcement reports |
| 2020-01-22 | Recall | FDA recall, Class II: Assurance Infusion. Lack of sterility assurance. | Regulator FDA enforcement reports |
| 2019-02-20 | Recall | FDA recall, Class II: Promise Pharmacy, LLC. Lack of sterility assurance. | Regulator FDA enforcement reports |
| 2015-12-15 | Trial | New trial registered: PCO-02 - Safety and Pharmacokinetics Trial | Trial register ClinicalTrials.gov |
From ClinicalTrials.gov, EU CTIS, FDA labels, recalls, shortages and warning letters, the Federal Register, and regulators' published actions. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.